-
Mashup Score: 3Colorectal cancer: guided by the gut? - ESMO Perspectives - 2 year(s) ago
Recent evidence suggests a role of the microbiome in cancer pathogenesis and as a potential therapeutic target, but it is still early days
Source: perspectives.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Can academic oncology compete with the career prospects offered by the pharma industry? - ESMO Perspectives - 2 year(s) ago
Moving back and forth across academic and corporate positions has become increasingly common for oncologists in search of new opportunities
Source: perspectives.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Can academic oncology compete with the career prospects offered by the pharma industry? Two experts reflect on trade-offs of moving between the two fields and long-term consequences of brain drain on #CancerResearch 👉https://t.co/xln0H2tOk3 https://t.co/1vqyTFewHk
-
-
Mashup Score: 4De-escalation of cancer treatments may be key to sustainability in oncology - ESMO Perspectives - 2 year(s) ago
Treating patients at reduced doses could contribute to a more efficient allocation of healthcare resources and improve access to costly treatments aroun…
Source: perspectives.esmo.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Being able to safely recommend cancer treatment at reduced doses is going to put a life-saving medicine within reach of many more women in the future in LMICs, says @oncology_bg https://t.co/ycJbZK2jBP via @myESMO
-
-
Mashup Score: 0De-escalation of cancer treatments may be key to sustainability in oncology - ESMO Perspectives - 2 year(s) ago
Treating patients at reduced doses could contribute to a more efficient allocation of healthcare resources and improve access to costly treatments aroun…
Source: perspectives.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#CancerTreatments at reduced doses could contribute to allocating healthcare resources & improving access globally, but the implementation of de-escalation in routine practice requires reliable & cost-effective tools #ESMOPerspectives 👉🏼 https://t.co/rePr0SPa5x https://t.co/zwnhAu6uxa
-
-
Mashup Score: 0Cancer treatment – how to wisely reduce its burden? A new ESMO tool to guide de-intensification - ESMO Perspectives - 2 year(s) ago
ESMO developed a classification to assess the risk-benefit ratio of treatment intensity modulation by a three-tiered approach
Source: perspectives.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#CancerTreatment – how to wisely reduce its burden? ESMO developed a framework to assess the risk-benefit ratio of treatment intensity modulation by a three-tiered approach for classifying evidence. #ESMOPerspectives 👉 https://t.co/PMrHdMtZZT @FAndreMD https://t.co/9tyvHzreJ4
-
-
Mashup Score: 9
Experience in breast cancer shows that treatment de-intensification must follow robust evidence, but also values and preferences to generate acceptance
Source: perspectives.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
How to discuss #CancerTreatment modulation w/ patients? Experience in #BreastCancer shows that treatment de-intensification must follow robust evidence, but also values & preferences to generate acceptance #ESMOPerspectives 👉https://t.co/1JCKhQKpqT https://t.co/6AO7jV7o8r
-
-
Mashup Score: 3
In recent conflicts, good response to the health needs of refugees with cancer in receiving countries is consequence of an analysis of local cancer cent…
Source: perspectives.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#ClinicalPratice: Local cancer centres’ capacity & special measures to avoid fragmented care are necessary to enable good responses to the health needs of refugees with #cancer in receiving countries. #ESMOPerspectives 👉https://t.co/74uc78KmiZ @SullivanProf https://t.co/zwIPFKUAan
-
-
Mashup Score: 0
The new FDA guidance could be an important step toward necessary change to give adequate representation of older adults in cancer clinical trials
Source: perspectives.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#Gerionc: The new FDA guidance could be an important step toward necessary change to give an adequate representation of older adults in #cancer clinical trials #ESMOPerspectives 👉https://t.co/176Wpm0EG0 @ElenaGarralda https://t.co/2z8uub0LQF
-
-
Mashup Score: 4
Having treatment protocols for the rich countries and alternative protocols for the poor ones still nurtures global health disparities
Source: perspectives.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
“There are two recipes to cure people: one for rich countries, one for poor countries. I don’t need to clarify which one may imply a sub-standard of care.” @darioT_ Food for thought in #ESMOPerspectives 👉https://t.co/2IPGF3FvNF https://t.co/mJSRDdQPNY
-
-
Mashup Score: 4What do non-oncologists know about cancer care? - 2 year(s) ago
A survey reveals that physicians outside the field of oncology are insufficiently updated on the latest advances in cancer care, thus increasing the risk of providing misleading information and inadequate support to patients.
Source: perspectives.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
What do non-oncologists know about #cancer care? GPs could play a key role in the management of acute symptoms and improve the continuum of #cancercare 👉https://t.co/hH9XxYDwIM @DoniaMarco @MassimoDiMaio75 #ESMOPerspectives #oncology https://t.co/eEwiQwZZFy
-
#ColorectalCancer: guided by the gut? @ElenaGarralda reviews recent evidence on targeting cancer microbiome and challenges ahead. 👉 Read the column on #ESMOPerspectives 📌https://t.co/MhQ0VAQxaM @VHIO https://t.co/slAuCbHf60